Anicequol
Anicequol, a microbial secondary metabolites, is an anchorage-independent growth of tumor cells inhibitor. Anicequol inhibits the anchorage-independent growth of human colon cancer DLD-1 cells with the IC50 of 1.2 μM[1].
Product Specifications
CAS Number
[440368-05-8]
UNSPSC
12352211
Target
Endogenous Metabolite
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Cancer
Smiles
C[C@@]12[C@](C[C@@H]([C@]2([H])[C@H](C)/C=C/[C@H](C)C(C)C)OC(C)=O)([H])[C@@]3([H])[C@@]([C@H](C1)O)([H])[C@@]4([C@@](C[C@H](CC4)O)([H])C([C@@H]3O)=O)C
Molecular Formula
C30H48O6
Molecular Weight
504.70
References & Citations
[1]Igarashi Y, et al. Anicequol, a novel inhibitor for anchorage-independent growth of tumor cells from Penicillium aurantiogriseum Dierckx TP-F0213. J Antibiot (Tokyo) . 2002 Apr;55 (4) :371-6.
Shipping Conditions
Room temperature
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-N13886/
Scientific Category
Natural Products
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
